Associate Director, Clinical Science

Isabella Premoli Ph.D.

Isabella joined atai Life Sciences in 2022.

Previously, Isabella was working as Imaging and Behavioral Biomarker Specialist at H. Lundbeck A/S where she was responsible for developing biomarker strategies to be implemented in early-phase clinical trials in the field of psychiatry and neurology.

Prior to that, she was a Postdoctoral Clinical Researcher at King’s College London where she was responsible for the implementation of brain stimulation-based biomarkers in commercial studies for the development of novel anti-epileptic drugs.

Isabella holds a Ph.D. in Behavioral Neuroscience from the International Max Planck School of Tübingen (Germany) and a Bachelor’s and Master’s degree in Chemistry and Pharmaceutical Technology from the University of Pavia (Italy).

<<  Back to our team